Case studies
- Investor Presentation for a Fintech Startup
- Fundraising
- Venture Capital
- Finance Strategy
- Web App to Explore Industry Metrics
- Data Visualization
- Big Data
- Data Science
- R
- Web App for Cryptocurrency Analysis
- Cryptocurrency
- R
Raphael Rottgen
Rio de Janeiro - State of Rio de Janeiro, Brazil
Member since August 22, 2017
Raphael was the co-founder of a fintech company which he grew to 50 employees and merged with a competitor after only four years. He's is currently a partner in a cryptocurrency hedge fund and worked for 15 years as a global equity investor and an investment banker at firms like Deutsche Bank and J.P. Morgan. He also holds a master's degree in AI. As a consultant, he's passionate about analyzing innovative businesses and helping them grow.
Raphael is now available for hire
Career Highlights
- Final Frontier Holdings
- Financiar Casa S/A
- Gandhara Capital
Education
- PUC | Pontifical Catholic University of Rio de Janeiro
- The Wharton School at the University of Pennsylvania
Select Certifications
- CFA Institute
- Global Association of Risk Professionals (GARP)
Industry Expertise
- Financial Services
Software Expertise
- R
Other Expertise
- Brazil
- Data Science
- Entrepreneurship
- Equity Research
- Mergers & Acquisitions (M&A)
- Strategy
Employment
- Head of Research | Chief Data Scientist2017 - PRESENTFinal Frontier Holdings
- Built a web-based data analysis tool for the top cryptocurrencies, considering both technical and fundamental data.
- Developed algorithms to automatically monitor a number of trading hypotheses for cryptocurrencies.
- Developed and wrote up specific investment hypotheses.
Focus areas: Valuation, Cryptocurrency, ICOs, Investment Thesis - Freelance Financial Analyst to Evaluate SpaceX2017 - 2017Investment Fund (via Toptal)
- Built a financial model for the business based on public information.
Focus areas: Financial Modeling, Valuation - Chief Investment Officer2015 - 2017SVM Capital
- Designed an investment process that augments human investment judgment with machine intelligence, for use in concentrated, fundamental long-short equity investment.
- Developed and maintained a suite of investment algorithms using machine learning techniques.
- Invested successfully in a current universe of over 1,300 stocks across all industries.
Focus areas: Equity Research, Equity Valuation, Private Equity, Valuation - Seed Investor | Chairman2008 - 2013Financiar Casa S/A
- Co-founded one of Brazil's first nationwide online mortgage brokerages, pioneering the concept in the local market wherein we were one of the first two companies.
- Developed some of the first-ever mortgage distribution partnerships with major banks (e.g., HSBC, Citibank, Santander, Itaú) and real estate developers.
- Specified and developed (with external IT support) a custom IT platform—including the public web portal—for mortgage marketing and processing.
- Successfully led two fundraising rounds—including fundraising meetings, negotiation, and closing documentation—with local and international investors.
- Recruited and managed up to 50 employees, in addition to outsourced service providers, across all of the company's functions, including sales, IT, finance, and HR.
- Conceived and negotiated the merger of the company with one of its competitors.
Focus areas: Financial Strategy, Fundraising - Investment Analyst2005 - 2007Gandhara Capital
- Generated and analyzed equity investment ideas globally and across sectors as a senior investment professional, helping the fund generate annual net returns in the mid-teens.
- Oversaw up to USD 750 million gross exposure (i.e., long and short), monitoring investment positions on a real-time basis.
- Conducted all the necessary primary and secondary research (including senior management meetings), financial modeling and other due diligence in order to develop conviction on investment ideas.
- Regularly updated fund's investors on investment positions via written reports and one-on-one meetings.
- Co-founded the firm with a team that had left Deutsche Bank where I had acted as a director of proprietary trading in essentially the same functional role.
Focus areas: Equity Research, Equity Valuation, Valuation - Director of Proprietary Trading2002 - 2005Deutsche Bank
- Joined a newly-formed proprietary investment team as a founding member focused on fundamental investment in global equities (based in Tokyo and London).
- Generated and analyzed equity investment ideas globally and across sectors as a senior investment professional, helping the team achieve investment returns in the mid-teens.
- Oversaw investment positions on a real-time basis, interacting with sell-side trading desks.
Focus areas: Equity Research, Equity Valuation, Valuation - Associate1998 - 2002Greenhill & Co.
- Served as the lead associate on the distressed restructuring of Marconi plc, advising the bondholders.
- Managed substantial parts of the local day-to-day processes during the sale of Optus (the second-largest Australian telecom at the time) to Singapore Telecom; it was one of the largest M&A transactions in Australia.
- Served as the associate on the team advising C&W on the sale of Hong Kong Telecom to PCCW which was the largest ever non-Japan Asia M&A transaction at the time; I performed tasks such as financial modeling and due diligence.
- Participated in tens of billions of dollars in deal value of other transactions globally.
Focus areas: Mergers & Acquisitions (M&A), Financial Restructuring - Financial Analyst1997 - 1998J.P. Morgan
- Served on various advisory assignments for industrial and defense clients in the Americas.
- Performed in-depth financial modeling, including forecasts, valuations, and pro forma merger analyses.
Focus areas: Mergers & Acquisitions (M&A)
Other Experience
- Biotech Valuation Idiosyncrasies and Best Practices (Publication)Biotech companies with little to no revenue can still be worth billions. Consider the most prominent 2017 biotech M&A deal when Gilead bought Kite Pharma for almost $12 billion. At the time of the deal, Kite had over $600 million in accumulated deficit, but it also had a pipeline of CAR-T cell therapies, which treat cancer. This article examines how to value such pipelines. It also focuses on the risk-adjusted NPV valuation methodology, portfolios of multiple drug candidates, and how value is impacted by the characteristics of the investor or acquirer.
- Investing in Cryptocurrencies: The Ultimate Guide (Publication)So, you’ve decided to get exposure to cryptocurrencies. In this newer space, a personal financial advisor may not be of great help. Neither will your banker, unless you are a customer of a limited number of progressive Swiss private banks, which facilitate crypto trading. What now? This article provides practical information and resources around passive vs. active cryptocurrency investing, how to buy, sell, store, and monitor cryptocurrencies, as well as tax regulations in the space.
Education
- Master's degree in Computer Science2013 - 2015PUC | Pontifical Catholic University of Rio de Janeiro - Rio de Janeiro, Brazil
- Bachelor's degree in Psychology1993 - 1997University of Pennsylvania - Philadelphia, PA, USA
- Bachelor's degree in Finance1993 - 1997The Wharton School at the University of Pennsylvania - Philadelphia, PA, USA
Certifications
- Chartered Financial Analyst (CFA)AUGUST 2016 - PRESENTCFA Institute
- Chartered Financial Risk Manager (FRM)JULY 2015 - PRESENTGlobal Association of Risk Professionals (GARP)
